Topics

CBD Tech News: Optivida Health Contracts with Frelii (OTCQB: FRLI) for DNA Sequencing Services to Maximize Hemp Extract and CBD Use, Alignment & Understanding by Customers

07:50 EDT 1 May 2019 | InvestorIdeas

LEHI, UT - May 1, 2019 (Investorideas.com Newswire) Frelii Inc. (OTCQB: FRLI) ("Frelii" or "The Company") today announced that it has signed a contract and licensing agreement with Optivida Health (Optivida), one of the nation's leaders in advanced hemp extract for the consumer market.

Original Article: CBD Tech News: Optivida Health Contracts with Frelii (OTCQB: FRLI) for DNA Sequencing Services to Maximize Hemp Extract and CBD Use, Alignment & Understanding by Customers

NEXT ARTICLE

More From BioPortfolio on "CBD Tech News: Optivida Health Contracts with Frelii (OTCQB: FRLI) for DNA Sequencing Services to Maximize Hemp Extract and CBD Use, Alignment & Understanding by Customers"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...